Projects

A wearable electronic tablet sized regenerative peritoneal dialysis cycler with intelligent monitoring for pediatric and adult patients with end-stage kidney disease (ESKD)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2028

Project Lead

Dr. Anil Vasudevan

Authors

Dr. Anil Vasudevan

Project Status

ongoing